SE453917B - Derivat av glycinamid samt framstellning derav och farmaceutisk komposition innehallande denna - Google Patents

Derivat av glycinamid samt framstellning derav och farmaceutisk komposition innehallande denna

Info

Publication number
SE453917B
SE453917B SE8002204A SE8002204A SE453917B SE 453917 B SE453917 B SE 453917B SE 8002204 A SE8002204 A SE 8002204A SE 8002204 A SE8002204 A SE 8002204A SE 453917 B SE453917 B SE 453917B
Authority
SE
Sweden
Prior art keywords
group
branched
formula
linear
straight
Prior art date
Application number
SE8002204A
Other languages
English (en)
Swedish (sv)
Other versions
SE8002204L (sv
Inventor
R Roncucci
C Gillet
A Cordi
M Martens
J Roba
P Niebes
G Lambelin
Dorsser W Van
Original Assignee
Continental Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from LU81068A external-priority patent/LU81068A1/fr
Priority claimed from LU81069A external-priority patent/LU81069A1/fr
Application filed by Continental Pharma filed Critical Continental Pharma
Publication of SE8002204L publication Critical patent/SE8002204L/xx
Publication of SE453917B publication Critical patent/SE453917B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/22—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE8002204A 1979-03-22 1980-03-21 Derivat av glycinamid samt framstellning derav och farmaceutisk komposition innehallande denna SE453917B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
LU81068A LU81068A1 (fr) 1979-03-22 1979-03-22 Derives de la glycinamide, leur preparation et utilisation, ainsi que compositions contenant ces derives
LU81069A LU81069A1 (fr) 1979-03-22 1979-03-22 Derive de glycinamide, preparation de ce derive, son utilisation ainsi que composition contenant ce derive

Publications (2)

Publication Number Publication Date
SE8002204L SE8002204L (sv) 1980-09-23
SE453917B true SE453917B (sv) 1988-03-14

Family

ID=26640253

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8002204A SE453917B (sv) 1979-03-22 1980-03-21 Derivat av glycinamid samt framstellning derav och farmaceutisk komposition innehallande denna

Country Status (18)

Country Link
US (1) US4639468A (sl)
AT (1) AT381302B (sl)
AU (1) AU536499B2 (sl)
CA (1) CA1184567A (sl)
CH (1) CH645091A5 (sl)
DE (2) DE3050800C2 (sl)
DK (1) DK162714C (sl)
ES (1) ES8104790A1 (sl)
FI (1) FI82033C (sl)
FR (1) FR2451913A1 (sl)
GB (1) GB2048852B (sl)
GR (1) GR68005B (sl)
IE (1) IE49751B1 (sl)
IL (1) IL59679A (sl)
NL (1) NL191508C (sl)
NO (1) NO157817C (sl)
PT (1) PT70992A (sl)
SE (1) SE453917B (sl)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2937698A1 (de) * 1979-09-18 1981-04-02 A. Nattermann & Cie GmbH, 5000 Köln N-propionylsarcosinanilide, deren herstellungsverfahren und arzneimittel auf deren basis
DK373383A (da) * 1982-08-20 1984-02-21 Midit Fremgangsmaade til fremstilling af omega-aminosyrederivater
US4798687A (en) * 1987-02-06 1989-01-17 Pennwalt Corporation 2-Amino-N-[1,2-Diphenyl-1-(thifluoromethyl)ethyl]acetamide derivatives
US4904681A (en) * 1987-12-01 1990-02-27 G. D. Searle & Co. D-cycloserine and its prodrugs as cognitive enhancers
US4891058A (en) * 1988-07-18 1990-01-02 Ici Americas Inc. 1-alkyl-3-aryl imidazolidine-2,4-diones and herbicidal use
US5278191A (en) * 1988-08-31 1994-01-11 G. D. Searle & Co. Diphenylmethylaminoacetamide derivatives as anti-convulsants
US5288905A (en) * 1988-10-07 1994-02-22 G. D. Searle & Co. Glycyl urea derivatives as anti-convulsants
US4944796A (en) * 1988-11-14 1990-07-31 Ici Americas Inc. Certain 2-(disubstituted amino) acetanilide herbicides
DE3915755A1 (de) * 1989-05-13 1990-11-29 Bayer Ag Fungizide mittel sowie substituierte aminosaeureamid-derivate und deren herstellung
IL94466A (en) * 1989-05-25 1995-01-24 Erba Carlo Spa Pharmaceutical preparations containing the history of A-amino carboxamide N-phenylalkyl are converted into such new compounds and their preparation
US5075337A (en) * 1989-07-26 1991-12-24 G. D. Searle & Co. Alpha-deuterated 2-alkylaminoacetamide derivatives having reduced toxicity for treatment of CNS disorders
US5153226A (en) * 1989-08-31 1992-10-06 Warner-Lambert Company Acat inhibitors for treating hypocholesterolemia
DE4102042A1 (de) * 1991-01-24 1992-07-30 Bayer Ag Substituierte aminosaeureamid-derivate deren herstellung und verwendung als fungizide
US5141960A (en) * 1991-06-25 1992-08-25 G. D. Searle & Co. Tricyclic glycinamide derivatives as anti-convulsants
GB9306899D0 (en) * 1993-04-01 1993-05-26 Erba Carlo Spa Substituted (arylalkylaminobenzyl) aminopropionamide derivatives and process for their preparation
GB9306886D0 (en) * 1993-04-01 1993-05-26 Erba Carlo Spa Substituted (arylakoxybenzyl) aminopropanamide derivatives and process for their preparation
US5585358A (en) * 1993-07-06 1996-12-17 Yissum Research Development Corporation Of The Hebrew University Of Jerusalem Derivatives of valproic acid amides and 2-valproenoic acid amides, method of making and use thereof as anticonvulsant agents
CN1327383A (zh) * 1996-05-31 2001-12-19 阿列里克斯神经科学公司 治疗神经和神经精神障碍的药物
US6191165B1 (en) * 1996-05-31 2001-02-20 Allelix Neuroscience Inc. Pharmaceutical for treatment of neurological and neuropsychiatric disorders
IT1283489B1 (it) * 1996-07-23 1998-04-21 Chiesi Farma Spa Ammidi di alfa-amminoacidi,loro preparazione e loro impiego terapeutico
GB9727523D0 (en) 1997-12-31 1998-02-25 Pharmacia & Upjohn Spa Alpha-aminoamide derivatives useful as analgesic agents
US6984754B1 (en) 1998-03-26 2006-01-10 University Of Saskatchewan Technologies Inc. Aliphatic amino carboxylic and amino phosphonic acids amino nitriles and amino tetrazoles as cellular rescue agents
ES2296383T3 (es) * 1998-03-26 2008-04-16 University Of Saskatchewan Acidos aminofosfonicos y aminocarboxilicos alifaticos, aminonitrilos y aminotetrazoles como agentes de restablecimiento de las funciones celulares.
US6346547B1 (en) * 1999-02-08 2002-02-12 Checkpoint, Genetics, Inc. N-substituted amino acids, antioxidant pharmaceutical compositions containing n-substituted amino acids and methods for preventing cardiovascular diseases and/or preventing and/or treating antioxidant responsive diseases therewith
NZ523917A (en) * 2000-07-21 2004-11-26 Teva Pharma Use of derivatives of valproic acid and 2-valproenic acid amides for the treatment of mania in bipolar disorder
HUP0401867A2 (hu) * 2000-08-17 2004-12-28 Teva Pharmaceutical Industries Ltd. A valproinsav-amid és a 2-valproénsav-amid származékainak használata a fájdalommal és a fejfájással járó betegségek kezelésére vagy megelőzésére
DE60134337D1 (de) * 2000-11-21 2008-07-17 Ucb Pharma Sa N-alkylierte gaba verbindungen, verfahren zu deren
BR0207307A (pt) 2001-02-16 2004-08-17 Allelix Neuroscience Inc Inibidores de glyt-1
US20030035784A1 (en) * 2001-03-05 2003-02-20 Kao Corporation Hair cosmetic, aminocarboxylic acid amide and method for producing the same
BRPI0212298B8 (pt) 2001-09-03 2021-05-25 Newron Pharm Spa composição farmacêutica compreendendo gabapentina ou um análogo da mesma e (alfa)-aminoamida e seu uso analgésico
EP1438956A1 (en) * 2003-01-16 2004-07-21 Newron Pharmaceuticals S.p.A. Alpha-aminoamide derivatives useful as antimigraine agents
RS51411B (en) * 2004-09-10 2011-02-28 Newron Pharmaceuticals S.P.A. USE (R) - (HALOBENZYLOXY) BENZYLAMINO-PROPANAMIDE AS SELECTIVE MODULATORS OF SODIUM AND / OR CALCIUM CHANNELS
CN101018843B (zh) * 2004-09-13 2011-05-11 西巴特殊化学品控股有限公司 烷基氨基乙酰胺润滑添加剂
FR2896991A1 (fr) * 2006-02-03 2007-08-10 Inst Nat Sante Rech Med Procede pour preparer un compose organique a l'etat solide et compositions pharmaceutiques comprenant ledit compose organique
CN102351733B (zh) * 2011-07-21 2014-03-19 凯莱英医药化学（阜新）技术有限公司 一种制备2-氨基-n,n-二甲基乙酰胺盐酸盐的方法
SI3766916T1 (sl) 2014-06-25 2023-01-31 Acuitas Therapeutics Inc. Formulacije novih lipidov in lipidnih nanodelcev za dostavo nukleinskih kislin
JP6053724B2 (ja) * 2014-06-26 2016-12-27 国立大学法人九州大学 イオン交換樹脂及び金属の吸着分離方法
WO2017004143A1 (en) 2015-06-29 2017-01-05 Acuitas Therapeutics Inc. Lipids and lipid nanoparticle formulations for delivery of nucleic acids
EP4212510A1 (en) 2015-10-28 2023-07-19 Acuitas Therapeutics Inc. Novel lipids and lipid nanoparticle formulations for delivery of nucleic acids
CN106187829B (zh) * 2016-07-29 2017-12-15 万华化学集团股份有限公司 一种制备乙二胺基乙磺酸盐的方法
WO2018191657A1 (en) 2017-04-13 2018-10-18 Acuitas Therapeutics, Inc. Lipids for delivery of active agents
CA3061612A1 (en) 2017-04-28 2018-11-01 Acuitas Therapeutics, Inc. Novel carbonyl lipids and lipid nanoparticle formulations for delivery of nucleic acids
EP3668833A1 (en) 2017-08-16 2020-06-24 Acuitas Therapeutics, Inc. Lipids for use in lipid nanoparticle formulations
US11524932B2 (en) 2017-08-17 2022-12-13 Acuitas Therapeutics, Inc. Lipids for use in lipid nanoparticle formulations
US11542225B2 (en) 2017-08-17 2023-01-03 Acuitas Therapeutics, Inc. Lipids for use in lipid nanoparticle formulations
WO2019036000A1 (en) * 2017-08-17 2019-02-21 Acuitas Therapeutics, Inc. LIPIDS FOR USE IN LIPID NANOPARTICLE FORMULATIONS
KR101953366B1 (ko) 2018-12-26 2019-02-28 정종문 침향을 포함하는 기억력 및 인지능력을 향상시키는 기능성 건강식품 및 이의 제조방법
WO2020146805A1 (en) 2019-01-11 2020-07-16 Acuitas Therapeutics, Inc. Lipids for lipid nanoparticle delivery of active agents
USD926577S1 (en) 2019-09-23 2021-08-03 Verdant Ventures Tamper-resistant lid assembly
US11326923B2 (en) 2019-10-08 2022-05-10 Verdant Ventures Tamper-resistant lid assembly for dispensing a premeasured amount of liquid
CA3189338A1 (en) 2020-07-16 2022-01-20 Acuitas Therapeutics, Inc. Cationic lipids for use in lipid nanoparticles

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2368208A (en) * 1940-12-16 1945-01-30 Emulsol Corp Chemical compounds and method of preparing same
US2781385A (en) * 1953-09-21 1957-02-12 Gefgy Chemical Corp Diamidocarboxylic acids and certain salts thereof
LU43649A1 (sl) * 1962-05-09 1963-07-16
JPS5319654B2 (sl) * 1974-03-14 1978-06-22
DE2832009A1 (de) * 1978-07-20 1980-01-31 Deutsches Krebsforsch Verwendung von sarkosin und sarkosinderivaten ls tumorhemmende wirksubstanzen

Also Published As

Publication number Publication date
NL191508B (nl) 1995-04-18
ES490536A0 (es) 1981-04-16
AU5678480A (en) 1980-09-25
PT70992A (fr) 1980-04-01
GR68005B (sl) 1981-10-26
GB2048852A (en) 1980-12-17
NO800830L (no) 1980-09-23
FR2451913A1 (fr) 1980-10-17
NO157817C (no) 1988-05-25
ATA154680A (de) 1986-02-15
NL8001721A (nl) 1980-09-24
GB2048852B (en) 1983-03-30
SE8002204L (sv) 1980-09-23
FI800900A (fi) 1980-09-23
IE49751B1 (en) 1985-12-11
DE3010599A1 (de) 1980-10-09
DE3050800C2 (sl) 1989-06-22
DK162714B (da) 1991-12-02
FR2451913B1 (sl) 1984-07-13
NL191508C (nl) 1995-08-21
AT381302B (de) 1986-09-25
DK123580A (da) 1980-09-23
IE800599L (en) 1980-09-22
NO157817B (no) 1988-02-15
DK162714C (da) 1992-04-21
AU536499B2 (en) 1984-05-10
US4639468A (en) 1987-01-27
FI82033B (fi) 1990-09-28
IL59679A (en) 1984-11-30
DE3010599C2 (sl) 1989-03-02
FI82033C (fi) 1991-01-10
IL59679A0 (en) 1980-06-30
CH645091A5 (fr) 1984-09-14
CA1184567A (en) 1985-03-26
ES8104790A1 (es) 1981-04-16

Similar Documents

Publication Publication Date Title
SE453917B (sv) Derivat av glycinamid samt framstellning derav och farmaceutisk komposition innehallande denna
AU707075B2 (en) Carbocyclic intermediates and process of manufacture thereof
DE69208868T2 (de) 5-heteroyl indol derivate
JP2564462B2 (ja) 新規アリールアルキル（チオ）アミド化合物
FR2606018A1 (fr) Nouveaux a-aminoacides substitues, leur preparation et leur utilisation en therapeutique comme medicaments
DK173576B1 (da) Di- og trisubstituerede N-cycloalkylalkylbenzylaminer, mellemprodukter til fremstilling af disse og medicinske præparater i
CS258149B2 (en) Method of arylcyclobutylalkylamines production
DK2890684T3 (en) URINARY COMPOUNDS AND THEIR USE AS ENZYMINE INHIBITORS
KR20040093123A (ko) Ｎｋ1 길항제
PL82184B1 (sl)
CA2767893C (fr) Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
CA2292927C (fr) Nouveaux composes imidazoliniques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
IE67166B1 (en) New phenylethanolamino- and phenylethanolaminomethyltetralines process for the preparation thereof inermediates in said process and pharmaceutical compositions containing them
JPH0653715B2 (ja) ２−アミノアセトアミド誘導体
JP4084855B2 (ja) 環式化合物の製法
NO168103B (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive aralkylimidazolderivater
CA1173857A (en) Fluorinated diaminobutane derivatives
LU85035A1 (fr) Derives d'amides d'acides amines,leurs preparation et utilisation ainsi que les compositions contenant ces derives
FR2717803A1 (fr) Dérivés substitués d'hétérocycles azotés et leurs isomères, actifs sur le système nerveux central, procédé d'obtention et compositions pharmaceutiques les contenant.
US20040236118A1 (en) Pyrrolidine derivatives and method of synthesizing these
CA3158052A1 (en) Process of preparing arachidonoylethanolamine analogues
JPS639491B2 (sl)
IT202000004075A1 (it) Processo per la preparazione di panobinostat
JPH09124630A (ja) カルバミン酸テトラヒドロフリルエステル誘導体の製造方法
EP2419431A1 (fr) Derives de n-[(7-aza-bicyclo[2.2.1]hept-1-yl)-aryl-methyl]-benzamide, leur preparation et leur application en therapeutique

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8002204-9

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 8002204-9

Format of ref document f/p: F